Epithalon (Epitalon) (10mg) Dosage Protocol
Epithalon is a tetrapeptide (Ala-Glu-Asp-Gly) that research suggests may activate telomerase, the enzyme responsible for maintaining telomere length. It is derived from epithalamin, a pineal gland extract.
Add 2.0 mL bacteriostatic water → 5 mg/mL (5000 mcg/mL)
5-10 mg daily for 10-20 day cycles
At 5 mg/mL: 10 units = 500 mcg, 100 units = 5 mg
Lyophilized: -20°C; Reconstituted: 2-8°C for up to 4 weeks
| Week | Daily Dose | Units (per injection) |
|---|---|---|
| Days 1-10 | 5 mg daily | 100 units (1.0 mL) |
| Days 11-20 | 5-10 mg daily | 100-200 units |
| Cycle off | 4-6 months | Before repeating |
- 1Draw 2.0 mL bacteriostatic water with a sterile syringe
- 2Inject slowly down the vial wall
- 3Gently swirl until fully dissolved
- 4Label with date and concentration, refrigerate immediately
Epithalon research suggests it may activate telomerase, allowing cells to maintain telomere length during division. Telomere shortening is associated with cellular aging. Studies in cell cultures and animal models showed increased telomerase activity and potential lifespan extension.
- Research suggests telomerase activation
- May support cellular longevity
- Studied for anti-aging properties
- Potential pineal gland support
- Khavinson VK, et al. Epithalon peptide induces telomerase activity. Bull Exp Biol Med. 2003
- Anisimov VN, et al. Effect of Epithalon on biomarkers of aging. Bull Exp Biol Med. 2001
- Telomerase activation and longevity research
Lyophilized
Store at -20°C, protected from light
Reconstituted
Refrigerate at 2-8°C, use within 4 weeks
Cycle 10-20 days on, 4-6 months off
- •Research compound - not FDA approved
- •Use in short cycles with long breaks
- •Part of Khavinson longevity research
- •Effects may be cumulative over cycles
Disclaimer: This content is intended for research and educational purposes only. Not intended to diagnose, treat, cure, or prevent any disease. All compounds are for research use only. Dosing information is derived from published scientific literature and clinical studies.